LOW-FRICTION FIRST PURCHASE

Before you spend $500,000 on a drug asset, spend $495 finding out what could kill it.

One asset. One indication. A fast human-reviewed screen designed to tell you whether the opportunity deserves deeper diligence.

Buy the $495 Rapid Asset Screen See a sample memo

The full $495 is credited toward a $4,950 Cheap-to-Truth Diligence Sprint if you upgrade within 14 days. If, after reviewing your submitted materials, we cannot identify a useful decision question for the Rapid Asset Screen, we refund the $495 rather than manufacture work.

WHAT IT IS

A filter before the full diligence machine.

Typical turnaround: 24–48 hours after complete inputs. This is a professional research screen, not clinical, legal or investment advice.

Gate

Safety, rights, scientific validity, regulator usability.

Signal

Human efficacy, biology, endpoint and recruitment reality.

Truth path

What is the cheapest credible experiment that could change the decision?

CREDITABLE UPGRADE

If the screen says “investigate,” the $495 becomes credit toward the full Sprint.

Buy the $495 screen